Pharmahungary Group as a Hungarian SME is ready for Horizon 2020 applications and are offering innovative preclinical and clinical R&D services.
Vezics exosome isolation platform SME Instrument Phase I grant winner
Pharmahungary Group and Zoltán Varga, MD, PhD won Seal of Excellence, CARDINFLAM grant proposal, non-alcoholic steatohepatitis (NASH) models
Pharmahungary Group scientific team attended the XXIII ISHR World Congress in Beijing, China
ESC Basic Science Summer School, Course Director Pharmahungary Group Founder & CEO